Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...

Scientists at a NY university say they can bring back the near extinct American chestnut tree, wiped out a century ago, ...

As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...

Genetic profiles and the gene editor CRISPR threaten to bring a new eugenics of gene selection, but even eugenicist Foster ...

A study in zebrafish shows that neuronal microexons regulate brain activity by modulating cAMP signaling. Loss of these ...

Genetic clues may help explain why sloths live at such a low gear. In a new study, researchers linked the animals' extremely ...

In a study published in Nature Communications, researchers at Karolinska Institutet have mapped key steps in the assembly of the mitochondrial ribosome, offering new clues to how defects in this ...

Silver nanoparticles provide a more efficient way to cut and assemble DNA, improving recovery rates and boosting DNA joining ...

Have you ever eaten a green potato, or a bunch of rhubarb leaves? Hopefully not, because these two plant parts can be toxic to humans. While they may seem edible, they contain chemicals that can make ...

Genetically modified organisms have been at the center of controversy for decades. But what does the science actually say? Modern genetic engineering allows scientists to introduce specific traits ...

Certain genetic variants, carried by around 10 percent of the population, could be making type 2 diabetes GLP-1 treatments (such as Ozempic and Wegovy) less effective, according to new research. These ...